Citation: | TIAN Xue, HUANG Liu, YAO Jing-qing, LI Yun-tao. Correlation analysis between serum Lp-PLA2 level and carotid atherosclerotic plaque[J]. Chinese Journal of General Practice, 2022, 20(11): 1848-1851. doi: 10.16766/j.cnki.issn.1674-4152.002717 |
[1] |
王亚楠, 吴思缈, 刘鸣. 中国脑卒中15年变化趋势和特点[J]. 华西医学, 2021, 36(6): 803-807. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYX202106017.htm
WANG Y N, WU S M, LIU M. Temporal trends and characteristics of stroke in China in the past 15 years[J]. West China Medical Journal, 2021, 36(6): 803-807. https://www.cnki.com.cn/Article/CJFDTOTAL-HXYX202106017.htm
|
[2] |
WU S M, WU B, LIU M, et al. Stroke in China: Advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405. doi: 10.1016/S1474-4422(18)30500-3
|
[3] |
MESCHIA J F, BUSHNELL C, BODEN-ALBALA B, et al. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2014, 45(12): 3754-3832. doi: 10.1161/STR.0000000000000046
|
[4] |
STAFFORINI D M. Plasma PAF-AH (PLA2G7): Biochemical properties, association with LDLs and HDLs, and regulation of expression[J]. Enzymes, 2015, 38: 71-93.
|
[5] |
CAO J, YAN P, ZHOU Y J, et al. Clinical utility of the serum level of lipoprotein-related phospholipase A2 in acute ischemic stroke with cerebral artery stenosis[J]. Front Neurol, 2021, 12: 642483. DOI: 10.3389/fneur.2021.642483.
|
[6] |
李振洲, 邵玉凤, 陈胜华, 等. 颈动脉斑块稳定性超声评估与血浆脂蛋白相关磷脂酶A2水平的相关性研究[J]. 中国临床医学影像杂志, 2019, 30(3): 166-168, 173. https://www.cnki.com.cn/Article/CJFDTOTAL-LYYX201903007.htm
LI Z Z, SHAO Y F, CHEN S H, et al. Correlation between stability of carotid plaque evaluated by ultrasound and the level of plasma Lp-PLA2[J]. Journal of China Clinic Medical Imaging, 2019, 30(3): 166-168, 173. https://www.cnki.com.cn/Article/CJFDTOTAL-LYYX201903007.htm
|
[7] |
张瑾, 潘凤华, 吴晋. 脑梗死患者脂蛋白相关磷脂酶A2水平及其与颈动脉斑块稳定性的相关性研究[J]. 系统医学, 2018, 3(14): 1-3. https://www.cnki.com.cn/Article/CJFDTOTAL-XTYX201814001.htm
ZHANG J, PAN F H, WU J. Study on Correlation between the Lipoprotein Associated Phospholipase A2 and Stability of Carotid Artery Plaque of Patients with Cerebral Infraction[J]. Systems Medicine, 2018, 3(14): 1-3. https://www.cnki.com.cn/Article/CJFDTOTAL-XTYX201814001.htm
|
[8] |
郝泽林, 吴建跃, 滕振飞, 等. 急性脑梗死患者血清学指标与神经功能缺损和脑梗死体积及颈动脉斑块性质的相关性研究[J]. 中华全科医学, 2020, 18(11): 1803-1806. doi: 10.16766/j.cnki.issn.1674-4152.001623
HAO Z L, WU J Y, TENG Z F, et al. Correlation of hs-CRP, MMP-9 and Lp-PLA2 with neurological deficit, cerebral infarction volume and carotid plaque properties in patients with acute cerebral infarction[J]. Chinese Journal of General Practice, 2020, 18(11): 1803-1806. doi: 10.16766/j.cnki.issn.1674-4152.001623
|
[9] |
中国医师协会神经内科医师分会神经超声专业委员会, 中华医学会神经病学分会神经影像协作组. 中国神经超声的操作规范(三)[J]. 中华医学杂志, 2017, 97(43): 3361-3370. doi: 10.3760/cma.j.issn.0376-2491.2017.43.001
Neuroultrasound Professional Committee of Chinese Medical Doctor Association, Neuroimaging Collaborative Group of Chinese Society of Neurology. Chinese Code of practice for neuroultrasound(3)[J]. National Medical Journal of China, 2017, 97(43): 3361-3370. doi: 10.3760/cma.j.issn.0376-2491.2017.43.001
|
[10] |
LIU H M, YAN Y, WANG Y X, et al. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study[J]. J Cell Mol Med, 2018, 22(10): 5145-5150.
|
[11] |
HUANG X Y, WANG A X, LIU X X, et al. Association between high sensitivity C-reactive protein and prevalence of asymptomatic carotid artery stenosis[J]. Atherosclerosis, 2016, 246: 44-49.
|
[12] |
SASAI M, ISO Y, MIZUKAMI T, et al. Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human[J]. Int J Cardiol, 2017, 227: 114-121.
|
[13] |
DENNIS E A, JIAN C, HSU Y H, et al. Phospholipase A2 enzymes: Physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention[J]. Chem Rev, 2011, 111(10): 6130-6185.
|
[14] |
HUANG F B, WANG K, SHEN J H. Lipoprotein-associated phospholipase A2: The story continues[J]. Med Res Rev, 2020, 40(1): 79-134.
|
[15] |
LIANG T, WANG S C, ZHANG D T, et al. Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction[J]. J Clin Lab Anal, 2020, 34(3): e23084. DOI: 10.1002/jcla.23084.
|
[16] |
陆强彬, 陆梦茹, 朱祖福, 等. 脂蛋白相关磷脂酶A2、脂蛋白(a)与脑梗死进展及头颈部血管狭窄的相关性[J]. 中国动脉硬化杂志, 2018, 26(12): 1270-1272, 1290. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201812016.htm
LU Q B, LU M R, ZHU Z F, et al. The correlation of lipoprotein associated phospholipase A2 and lipoprotein(a) with progress of cerebral infarction and the vascular stenosis of intracranial and external[J]. Chinese Journal of Arteriosclerosis, 2018, 26(12): 1270-1272, 1290. https://www.cnki.com.cn/Article/CJFDTOTAL-KDYZ201812016.htm
|
[17] |
ALSULAIMANI S, GARDENER H, ELKIND M, et al. Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study[J]. Stroke, 2013, 44(2): 457-461.
|
[18] |
WEI L L, KE Z Y, ZHAO Y, et al. The elevated lipoprotein-associated phospholipase A2 activity is associated with the occurrence and recurrence of acute cerebral infarction[J]. Neuroreport, 2017, 28(6): 325-330.
|
[19] |
王亚飞, 李惠勉. 动脉粥样硬化血栓形成性脑梗死患者血清Lp-PLA2水平变化及其意义[J]. 山东医药, 2018, 58(11): 72-74. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201811022.htm
WANG Y F, LI H M. Changes and significance of serum LP-PLA2 levels in patients with atherosclerotic thrombotic cerebral infarction[J]. Shandong Medical Journal, 2018, 58(11): 72-74. https://www.cnki.com.cn/Article/CJFDTOTAL-SDYY201811022.htm
|
[20] |
STEFANO A D, MA NN UCCI L, TAMBURI F, et al. Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases[J]. Int J Immunopathol Pharmacol, 2019, 33: 205873841982715. DOI: 10.1177/2058738419827154.
|